Recombinant Human MTOR Protein, N-His
Recombinant Human MTOR Protein, N-Hisexpressed in E. coli , spanning Phe1720-Ala2020. Purity: >90% by SDS-PAGE. Highlights His-Tagged: N-terminal 6xHis tag for IMAC purification. E. coli Expression: High-yield, cost-effective production. High Purity: >90% purity verified by SDS-PAGE.
Product Specifications
Product Name Alternative
RAFT1, Rapamycin target protein 1, Mechanistic target of rapamycin, FRAP, FKBP12-rapamycin complex-associated protein, mTOR, FRAP1, FK506-binding protein 12-rapamycin complex-associated protein 1, Rapamycin and FKBP12 target 1, FRAP2, RAPT1, Serine/threonine-protein kinase mTOR, Mammalian target of rapamycin, MTOR
UniProt
P42345
Expression Region
Phe1720-Ala2020
Origin
Homo sapiens (Human)
Field of Research
Cell Biology
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Form
Lyophilized
Molecular Weight
36.2 kDa
Storage Conditions
-20°C
Notes
For research use only.
Tested Applications
ELISA, SDS-PAGE, WB
Preservative
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1 mM EDTA, 4% Trehalose, 1% Mannitol.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![3-Dibenz[b, e]oxepin-11 (6H) -ylidene-N-methyl-N- (methyl-d3) -1-propanamine](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
425394-01 1 mg
3-Dibenz[b, e]oxepin-11 (6H) -ylidene-N-methyl-N- (methyl-d3) -1-propanamine
Sign In for Pricing
View Details 425394-02 2.5 mg
3-Dibenz[b, e]oxepin-11 (6H) -ylidene-N-methyl-N- (methyl-d3) -1-propanamine
Sign In for Pricing
View Details 
252780-ML650 100 µL
TLX3 (T-Cell Leukemia Homeobox 3, HOX11L2, MGC29804, RNX) (MaxLight 650)
Sign In for Pricing
View Details MBS6438727-01 0.1 mL
SPINK1 (Serine Protease Inhibitor Kazal-type 1, PCTT, PSTI, Spink3, TATI, TCP) (PE)
Sign In for Pricing
View Details MBS6438727-02 5x 0.1 mL
SPINK1 (Serine Protease Inhibitor Kazal-type 1, PCTT, PSTI, Spink3, TATI, TCP) (PE)
Sign In for Pricing
View Details 